Data

Data Use and Access Policy has been developed with­in the com­munity and with the involve­ment of sev­er­al experts. The cur­rent ver­sion can be found here.

On Sunday April 12^th 2020 after imple­ment­ing a data clean­ing and data anonym­iz­a­tion pro­cess we star­ted pub­lish­ing the pub­lic data set of the LEOSS cohort study.

The LEOSS pub­lic data set con­sti­tutes patient data from the LEOSS cohort after a data clean­ing pro­cess, e.g. veri­fic­a­tions for a com­plete doc­u­ment­a­tion of course of dis­ease and plaus­ib­il­ity checks. Vari­ables included are:

• age
• gender
• month of diagnosis
• clas­si­fic­a­tion of the present clin­ic­al phases
• out­come
• pres­ence of admin­istered vasopressor agents
• per­formed invas­ive ventilation
• super­in­fec­tions (proven/​suspected/​probable as one category)
• remain­ing symp­toms in the recov­ery phase 

The pub­lic data set is anonym­ized using our data pro­tec­tion concept. Sev­er­al para­met­ers refer to clin­ic­al phases. Val­ues where the respect­ive phase was not present have been defined as Not applic­able (N/​a)